About Avvio Medical

Our Vision
Avvio Medical Technology is dedicated to providing the safest and most effective treatment for harmful biomineralization and urinary stone disease. We envision a world free from the detrimental effects of excess biomineralization in the body.
Our Mission
Avvio’s initial medical therapy will offer patients and healthcare professionals a fast, minimally invasive solution for treating urinary stone disease in various clinical or outpatient settings, eliminating the routine need for anesthesia or X-ray imaging.
Our Quality Policy
Avvio Medical designs, develops, manufactures and distributes safe and effective medical devices for urinary stone disease and other human health conditions. We are committed to quality and the continuing effectiveness of our Quality Management System to meet customer and regulatory expectations.
Our Management Team

Paul Molloy
Chief Executive Officer

Rohit Girotra
Vice President of Product Development

Susie Lahey
Vice President of Corporate Administration
& Human Resources

Louis Marcoux
Vice President of Regulatory, Quality and Clinical Affairs

Alice Luong, PhD
Director of Technical Operations
& Head of Chemistry

Amy Sasser
Director of Clinical Affairs
Our Board of Directors

Paul Molloy

Thomas Kenny, PhD

Alex Andrianopoulos

Theresa Yu

Biao He, PhD

Barry Templin

Dongxue Wang
